News

ARC Medical Treats First Patient in JOCOAT™ Orthopedic Surgery, GLAD-04 Pivotal Clinical Trial

ARC Medical, a leader in surgical adhesion prevention innovation, today announced treatment of the first patient in the GLAD-04 clinical trial evaluating JOCOAT for the prevention or reduction of surgical adhesions in knee anterior cruciate ligament (ACL) repair surgery patients. JOCOAT liquid surgical adhesion barrier device is easily and rapidly applied into the joint at the end of an orthopedic surgery in arthroscopy and open procedures. JOCOAT then flows throughout the joint and provides a temporary, physical barrier that mechanically separates the tissues and prevents or reduces surgical adhesions throughout the entire joint.

Read More

ARC Medical Announces JOCOAT™ Successfully Deployed in 20th Orthopedic Surgery Patient

ARC Medical, a leader in surgical adhesion prevention innovation, announced the successful deployment of JOCOAT™ in its 20th orthopedic surgery patient. The company’s JOCOAT liquid surgical adhesion barrier medical device was used in 16 knee surgery patients and 4 shoulder surgery patients. In all surgeries, the application of JOCOAT™ and patient recoveries went smoothly. Early clinical data suggest there may be an improvement in the affected joint’s range of motion and patient mobility after surgery plus JOCOAT™ application, compared with their pre-operative function.

Read More

ARC Medical Announces IPCOAT™ GLAD-01 Clinical Safety Data and Nonclinical Data at AAGL 2025

ARC Medical, a leader in surgical adhesion prevention innovation, formally presented the company’s GLAD-01 safety clinical trial results for IPCOAT at the 54th AAGL Global Congress on Minimally Invasive Gynecologic Surgery (“AAGL”) held in Vancouver, Canada on November 8-11, 2025. IPCOAT, a novel liquid surgical adhesion barrier medical device, was safe, well tolerated and accepted in the randomized, controlled, double blinded GLAD-01 safety clinical trial with 76 healthy volunteers. A series of nonclinical safety and efficacy studies and mechanism of action studies were also presented at AAGL, demonstrating the efficacy and liquid adhesion barrier device mechanism of action of IPCOAT. ARC is now initiating a clinical trial with IPCOAT in gynecologic endometriosis surgery patients, based on the IPCOAT data. 

Read More

ARC Medical Announces IPCOAT™ Medical Device Presentations at AAGL 2025

ARC Medical Inc., a clinical stage medical device company focused on advancing surgical adhesion prevention, today announced that three scientific abstracts highlighting one of its lead medical devices, IPCOAT™, have been accepted for presentation at the 2025 AAGL 54th Global Congress on Minimally Invasive Gynecologic Surgery, taking place November 8–11 in Vancouver, BC, Canada. 

Read More

ARC Medical Announces 2025 H1 Conference Schedule

January 10, 2025 – ARC Medical Inc., an innovator in surgical adhesion prevention devices, today announced its planned participation in key medical and investor conferences throughout the first half of 2025. These events will provide ARC with the opportunity to engage with partners, investors and clinicians, while staying at the forefront of advancements in healthcare. 

Read More

ARC Completes USD $3M Financing to Advance Clinical Trials

Nov 19, 2024 – ARC Medical Inc. (ARC), a leader in surgical adhesion prevention, today announced the successful completion of the Company’s latest financing, securing USD $3 million. “ARC’s fundraising reaffirms investor confidence in our JOCOAT™ and IPCOAT™ liquid medical devices, in clinical development for the prevention of orthopedic and gynecological & abdominal surgical adhesions, respectively,” stated ARC’s CEO, Dr. Chris Springate.

Feb 22, 2024 – ARC Medical Inc. (ARC), a leading innovator in advanced medical devices, is pleased to announce its participation in a series of premier life sciences conferences throughout the first half of 2024. These events will showcase ARC Medical’s development and commercialization strategies for its novel pipeline of clinical stage, fluid medical devices for the prevention of surgical adhesions.